Skip to main content

Table 3 Predictors for mortality

From: Endoscopic variceal obturation and retrograde transvenous obliteration for acute gastric cardiofundal variceal bleeding in liver cirrhosis

Variables

Rating

Univariate analysis

Hazard ratio

95% CI

P value

Age

Years

1.005

0.979ā€“1.031

0.721

Sex

0ā€‰=ā€‰women; 1ā€‰=ā€‰men

1.418

0.702ā€“2.865

0.330

Diabetes

0ā€‰=ā€‰no; 1ā€‰=ā€‰yes

1.039

0.559ā€“1.932

0.904

Etiology

0ā€‰=ā€‰other; 1ā€‰=ā€‰alcohol

1.750

0.959ā€“3.195

0.068

Hemoglobin

g/dL

1.003

0.896ā€“1.124

0.955

Platelet count

Ɨā€‰109/L

0.998

0.992ā€“1.005

0.613

INR

Ā 

1.268

0.860ā€“1.871

0.231

Alanine aminotransferase

IU/L

1.001

0.995ā€“1.007

0.748

Total bilirubin

mg/dL

1.050

0.992ā€“1.110

0.090

Serum albumin

g/dL

0.674

0.363ā€“1.252

0.212

MELD score

Ā 

1.089

1.030ā€“1.151

0.002

Type of varices

0ā€‰=ā€‰GOV2; 1ā€‰=ā€‰IGV1

1.696

0.932ā€“3.085

0.084

Type of treatment

0ā€‰=ā€‰RTO; 1ā€‰=ā€‰EVO

1.174

0.648ā€“2.127

0.598

Beta-blocker

0ā€‰=ā€‰no; 1ā€‰=ā€‰yes

1.381

0.741ā€“2.574

0.309

Post EVL

0ā€‰=ā€‰no; 1ā€‰=ā€‰yes

1.570

0.859ā€“2.866

0.142

  1. IGV1 isolated gastric varices type 1, GOV2 gastroesophageal varices type 2, INR international normalized ratio, MELD model for end-stage liver disease, EVO endoscopic variceal obturation, RTO retrograde transvenous obliteration, EVL endoscopic variceal ligation